61755-005 : Eylea 40 mg/ml Intravitreal Injection, Solution
NDC: | 61755-005 |
Labeler: | Regeneron Pharmaceuticals, Inc. |
Product Type: | Human Prescription Drug |
Drug Name: | Eylea |
Dosage Form: | Intravitreal Injection, Solution |
Application #: | BLA125387 |
Rev. Date: |
NDC Package Codes:
- 61755-005-01: 1 SYRINGE, GLASS IN 1 CARTON (61755‑005‑01) > .05 ML IN 1 SYRINGE, GLASS
- 61755-005-02: 1 VIAL, SINGLE‑USE IN 1 CARTON (61755‑005‑02) > .05 ML IN 1 VIAL, SINGLE‑USE
- 61755-005-54: 1 SYRINGE, GLASS IN 1 CARTON (61755‑005‑54) > .05 ML IN 1 SYRINGE, GLASS
- 61755-005-55: 1 VIAL, SINGLE‑USE IN 1 CARTON (61755‑005‑55) > .05 ML IN 1 VIAL, SINGLE‑USE
Active Ingredients:
- Aflibercept
Dosage Strength:
- 40 mg/mL
Pharmaceutical Classes:
- Vascular Endothelial Growth Factor Inhibitor [EPC]
- Vascular Endothelial Growth Factor Inhibitors [MoA]
NDC QR Code
Scan the QR code below to easily reference this data in the future:< Prev: 61755-001Next: 61755-008 >
Related Discussions:
Eylea injection
Has anyone experienced loss of smell and taste since getting injections? ## What did your retinal specialist say about t... 7 replies
Has anyone experienced loss of smell and taste since getting injections? ## What did your retinal specialist say about t... 7 replies
Note: The RxChat NDC Database uses publicly available data from the FDA and the U.S. National Library of Medicine (NLM); The NLM is not responsible for the data presented and does not endorse or recommend this or any other product. While we make every effort to ensure that the information presented is accurate, you should assume that all results are unvalidated. To report any errors or inconsistencies please contact us.